MedTrace Logo

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

NCT03026998 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-09-15

No results posted yet for this study

Summary

The purpose of this study is to assess the benefit of MR screening for asymptomatic head \& neck (or CNS) second primary cancers occurring in hereditary retinoblastoma patients previously treated by external beam radiation therapy (EBRT).

Conditions

  • Hereditary Retinoblastoma

Interventions

PROCEDURE

MRI

MRI will be performed each year during 10 years.

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Hervé BRISSE, MD · NSTITUT CURIE

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-19
Primary Completion
2034-03-31
Completion
2034-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03026998 on ClinicalTrials.gov